5AM Ventures IV, L.P., 10% Owner at Aprea Therapeutics, Inc. (APRE), bought 2,247,243 shares at $15.00 ($5.0M) on 2019-10-07, disclosed to the SEC on 2019-10-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,913,910 | $0 | 0.0% |
| 2 | $15.00 | 333,333 | $5.0M | 100.0% |
| Total | $2.22 avg | 2,247,243 | $5.0M | 100% |
| Filing → |